Sino Biopharmaceutical

1177.HK · Healthcare · HKD

Latest Observation

Q4 2024

RG Metrics

RG8 Q4 2024 0.9

RG10 Q4 2024 0.8

RG12 Q4 2024 0.7

Trend

- Declining

Supporting Data

Market Cap (approx.)	HKD 45.8B
Tangible Equity (TE)	HKD 30.3B
Smoothed Earnings G (ann.)	HKD 2.9B
Fundamental Base FB₁₀	HKD 59.4B

in billions.

Data Note

Computed via yfinance. Historical end-of-quarter closing price × current shares outstanding. Older quarters estimated from annual NI / 4. Approximation.

Historical RG Values

Historical RG chart not yet available for this company.

All values are illustrative approximations and are provided for research purposes only. Not investment advice.